| [notice] |
2026년 학회 및 전시정보  |
관리자 |
2026.01.01 |
663 |
| 26 |
[Citation] N-terminal thrombospondin-1 enhances muscle function and  |
ybiologics |
2026.10.30 |
116 |
| 25 |
Dual-Platform Solution for Next-Generation CAR-T Development |
ybiologics |
2026.09.01 |
325 |
| 24 |
[논문] Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery  |
ybiologics |
2026.08.31 |
356 |
| 23 |
Human IgG subclasses (IgG1, IgG2, IgG3, IgG4) |
ybiologics |
2026.07.01 |
877 |
| 22 |
[Citation] Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells  |
ybiologics |
2026.04.27 |
3,814 |
| 21 |
[Citation] Structural Insights into Modulation of Neurexin-Neuroligin Trans-synaptic Adhesion  |
ybiologics |
2026.04.20 |
1,207 |
| 20 |
[논문] A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO  |
ybiologics |
2026.04.06 |
387 |
| 19 |
[Citation] A therapeutic human antibody against the domain 4 of the Bacillus anthracis  |
ybiologics |
2026.03.26 |
483 |
| 18 |
[논문] B cell depletion in autoimmune diseae (In vivo CAR-T or T cell enagers)  |
ybiologics |
2026.03.18 |
402 |
| 17 |
[Technical Support] Engineering and reformatting your antibody from mAb to bsAb  |
ybiologics |
2026.03.10 |
450 |
| 16 |
[Citation] Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis  |
ybiologics |
2026.03.02 |
419 |
| 15 |
[Citation] Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice  |
ybiologics |
2026.02.20 |
423 |
| 14 |
[논문] Antibodies to watch in 2026  |
ybiologics |
2026.02.03 |
407 |
| 13 |
[Technical Support] The real-time kinetic and affinity data for bsAb or Fc engineering  |
ybiologics |
2026.01.23 |
356 |
| 12 |
[논문] Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity,  |
ybiologics |
2025.12.15 |
494 |
| 11 |
[Citation] Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis  |
ybiologics |
2025.11.26 |
620 |
| 10 |
[논문] Developability considerations for bispecific and multispecific antibodies  |
ybiologics |
2025.11.18 |
551 |
| 9 |
[Citation] Endogenous DEL-1 restrains melanoma lung metastasis by limiting  |
ybiologics |
2025.11.11 |
442 |
| 8 |
[논문] Bispecific antibodies: advancing precision oncology  |
ybiologics |
2025.11.03 |
462 |
| 7 |
[Citation] Colony-stimulating factor 3  |
ybiologics |
2025.10.17 |
523 |